loadpatents
name:-0.0050489902496338
name:-0.0054929256439209
name:-0.00047492980957031
Takeshima; Yasuhiro Patent Filings

Takeshima; Yasuhiro

Patent Applications and Registrations

Patent applications and USPTO patent grants for Takeshima; Yasuhiro.The latest application filed is for "ena nucleic acid pharmaceuticals capable of modifying splicing of mrna precursors".

Company Profile
0.14.8
  • Takeshima; Yasuhiro - Nishinomiya N/A JP
  • Takeshima; Yasuhiro - Kobe N/A JP
  • Takeshima; Yasuhiro - Kobe-shi N/A JP
  • Takeshima; Yasuhiro - Hyogo N/A JP
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors
Grant 9,657,050 - Matsuo , et al. May 23, 2
2017-05-23
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors
Grant 9,657,049 - Matsuo , et al. May 23, 2
2017-05-23
ENA nucleic acid pharmaceuticals capable of modifying splicing of mRNA precursors
Grant 9,243,026 - Matsuo , et al. January 26, 2
2016-01-26
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS
App 20160002636 - MATSUO; Masafumi ;   et al.
2016-01-07
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS
App 20140316123 - Matsuo; Masafumi ;   et al.
2014-10-23
ENA nucleic acid drugs modifying splicing in mRNA precursor
Grant 8,624,019 - Matsuo , et al. January 7, 2
2014-01-07
ENA NUCLEIC ACID PHARMACEUTICALS CAPABLE OF MODIFYING SPLICING OF mRNA PRECURSORS
App 20130090465 - MATSUO; Masafumi ;   et al.
2013-04-11
ENA nucleic acid drugs modifying splicing in mRNA precursor
Grant 7,902,160 - Matsuo , et al. March 8, 2
2011-03-08
ENA NUCLEIC ACID DRUGS MODIFYING SPLICING IN mRNA PRECURSOR
App 20110046360 - MATSUO; Masafumi ;   et al.
2011-02-24
Ena nucleic acid drugs modifying splicing in mrna precursor
App 20070082861 - Matsuo; Masafumi ;   et al.
2007-04-12
Medicament for treatment of Duchenne muscular dystrophy
Grant 6,653,467 - Matsuo , et al. November 25, 2
2003-11-25

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed